NeuroPace (NPCE) Announces Two Management Appointments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
NeuroPace Strengthens Management Team with Two Key Appointments
September 4, 2024 4:05 PM EDTAppointed former key developer of RNS System as new Vice President of Research and Development
Appointed former head of commercial marketing for Boston Scientifics DBS franchise as the new Vice President of Marketing
MOUNTAIN VIEW, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced the appointments of Brett Wingeier as the new Vice President of Research and Development and Katie Keller as the new... More
